CSIMarket Company Name, Ticker, Competitors, else..


Qiagen N v   (NYSE: QGEN)
Other Ticker:  
 

Qiagen N v

QGEN's Fundamental analysis



Looking into Qiagen N V growth rates, revenue grew by 0.98 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 3084

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.45 %

Qiagen N V 's net profit decreased by -75.51 % in IV. Quarter 2024 year on year, to $84 millions.

• More on QGEN's Growth


Qiagen N V
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Qiagen N V realized cash reduction of $ -0.02 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
114.38
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.95.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.17.


• More on QGEN's Valuation
 
 Total Debt (Millions $) 1,392
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 330,922
 Net Income/Employee (TTM) $ 14,412
 Receivable Turnover (TTM) 5.5
 Tangible Book Value (Per Share $) 3.73

Qiagen N V
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Qiagen N V realized cash outflow of $ -0.02per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
114.38
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.95.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.17.

Qiagen N V Price to Book Ratio is at 2.67 lower than Industry Avg. of 18208.3. and higher than S&P 500 Avg. of 0.01

• More on QGEN's Valuation

•  Market Capitalization (Millions $) 9,510
•  Shares Outstanding (Millions) 225
•  Employees 5,800
•  Revenues (TTM) (Millions $) 1,919
•  Net Income (TTM) (Millions $) 84
•  Cash Flow (TTM) (Millions $) -5
•  Capital Exp. (TTM) (Millions $) -171
•  Total Debt (Millions $) 1,392
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 330,922
•  Net Income/Employee(TTM) $ 14,412
•  Receivable Turnover Ratio (TTM) 5.5
•  Tangible Book Value (Per Share $) 3.73

•  Market Capitalization (Millions $) 9,510
•  Shares Outstanding (Millions) 225
•  Employees 5,800
•  Revenues (TTM) (Millions $) 1,919
•  Net Income (TTM) (Millions $) 84
•  Cash Flow (TTM) (Millions $) -5
•  Capital Exp. (TTM) (Millions $) -171